Correlation Between Aarey Drugs and Fortis Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aarey Drugs and Fortis Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aarey Drugs and Fortis Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aarey Drugs Pharmaceuticals and Fortis Healthcare Limited, you can compare the effects of market volatilities on Aarey Drugs and Fortis Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aarey Drugs with a short position of Fortis Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aarey Drugs and Fortis Healthcare.

Diversification Opportunities for Aarey Drugs and Fortis Healthcare

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Aarey and Fortis is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Aarey Drugs Pharmaceuticals and Fortis Healthcare Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortis Healthcare and Aarey Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aarey Drugs Pharmaceuticals are associated (or correlated) with Fortis Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortis Healthcare has no effect on the direction of Aarey Drugs i.e., Aarey Drugs and Fortis Healthcare go up and down completely randomly.

Pair Corralation between Aarey Drugs and Fortis Healthcare

Assuming the 90 days trading horizon Aarey Drugs Pharmaceuticals is expected to under-perform the Fortis Healthcare. But the stock apears to be less risky and, when comparing its historical volatility, Aarey Drugs Pharmaceuticals is 1.15 times less risky than Fortis Healthcare. The stock trades about -0.33 of its potential returns per unit of risk. The Fortis Healthcare Limited is currently generating about -0.18 of returns per unit of risk over similar time horizon. If you would invest  71,900  in Fortis Healthcare Limited on November 6, 2024 and sell it today you would lose (7,880) from holding Fortis Healthcare Limited or give up 10.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Aarey Drugs Pharmaceuticals  vs.  Fortis Healthcare Limited

 Performance 
       Timeline  
Aarey Drugs Pharmace 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aarey Drugs Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Fortis Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fortis Healthcare Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Fortis Healthcare is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Aarey Drugs and Fortis Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aarey Drugs and Fortis Healthcare

The main advantage of trading using opposite Aarey Drugs and Fortis Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aarey Drugs position performs unexpectedly, Fortis Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortis Healthcare will offset losses from the drop in Fortis Healthcare's long position.
The idea behind Aarey Drugs Pharmaceuticals and Fortis Healthcare Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Global Correlations
Find global opportunities by holding instruments from different markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device